| Transcriptional and posttranscriptional regulation of the plasminogen activator system. | |
| | |
MedLine Citation:
|
PMID: 15841310 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The core protein components of the plasminogen activator (PA) system are two plasminogen activators, two plasminogen activator inhibitors and a urokinase type plasminogen activator-specific cell surface receptor. Various types of biological regulation are exerted through the interplay of these components mutually and with extracellular matrix proteins and cell membrane proteins, with or without involving proteolytic activity. Reflecting these diverse biological roles, the level and activity of each component of the PA system is under the control of a variety of regulatory mechanisms. The expression level of a protein reflects the level of the corresponding mRNA, which is essentially the net result of de novo synthesis, i.e. transcription, and degradation. Many recent studies have shown that the regulation of mRNA stability is dynamic and cell specific. Accordingly, we are learning that the mRNAs of the PA system are also the subject of diverse regulatory mechanisms. In this short review, we summarize current understanding of the transcriptional and mRNA-stability regulation of the PA system. |
| | |
Authors:
|
Yoshikuni Nagamine; Robert L Medcalf; Pura Muñoz-Cánoves |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Thrombosis and haemostasis Volume: 93 ISSN: 0340-6245 ISO Abbreviation: Thromb. Haemost. Publication Date: 2005 Apr |
Date Detail:
|
Created Date: 2005-04-20 Completed Date: 2005-09-13 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 7608063 Medline TA: Thromb Haemost Country: Germany |
Other Details:
|
Languages: eng Pagination: 661-75 Citation Subset: IM |
Affiliation:
|
Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, CH-4058 Basel, Switzerland. yoshikuni.nagamine@fmi.ch |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adipocytes
/
metabolism Gene Expression Regulation* Humans Plasminogen Activators / genetics* Plasminogen Inactivators / genetics RNA Processing, Post-Transcriptional RNA Stability Transcription, Genetic Urokinase-Type Plasminogen Activator / genetics |
| Chemical | |
Reg. No./Substance:
|
0/Plasminogen Inactivators; EC 3.4.21.-/Plasminogen Activators; EC 3.4.21.73/Urokinase-Type Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tissue plasminogen activator in central nervous system physiology and pathology.
Next Document: Plasminogen activation and cancer.